Ionchannels and channelopaties in the heart. Viktória Szőts

Similar documents
Ionchannels and channelopaties in the heart

Gene annotation for heart rhythm. 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5.

Genetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.

Strength and weakness of genetic testing in clinical routine.

Basics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD

Genetic testing in Cardiomyopathies

Molecular Physiology of Ion Channels That Control Cardiac Repolarization

Genetic Testing for Cardiac Ion Channelopathies

Rhythm and Blues Drugs and QT Prolongation

Prolonged QT Syndromes: Congenital and Acquired

Differences in cardiac atrial and ventricular ion channels

Preventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete

Name of Presenter: Marwan Refaat, MD

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

Curriculum vitae Balázs Ördög

Description. Page: 1 of 31. Genetic Testing for Cardiac Ion Channelopathies. Last Review Status/Date: December 2015

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Molecular and genetic basis of sudden cardiac death

Is There a Genomic Basis to Acquired Channelopathic disease

Genetic Testing for Cardiac Ion Channelopathies. Description

Sudden Unexplained Death in Epilepsy (SUDEP) and Dravet Syndrome

CONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT.

Protocol. Genetic Testing for Cardiac Ion Channelopathies

Phenotypic Manifestations of Mutations in Genes Encoding Subunits of Cardiac Potassium Channels

Case studies in Channelopathies

Normal heart rhythm requires the finely orchestrated

Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies

The action potential and the underlying ionic currents. Norbert Jost, PhD

What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment. Andreas Pflaumer

Mechanism of Action of the Antiarrhythmic Agent AZD7009

Wojciech Szczepański, MD, PhD Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division Medical University of Bialystok

Genetic Basis of Ventricular Arrhythmias

Long QT. Long QT Syndrome. A Guide for Patients

Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Sodium Channel

TdP Mechanisms and CiPA

Cardiac arrhythmias are associated with high morbidity

Inherited Arrhythmia Syndromes

Corporate Medical Policy

Deposited on: 29 October 2009

Antiarrhythmic Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2017

Antiarrhythmic Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Genomics and Cardiac Arrhythmias

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

Section: Effective Date: Subsection: Original Policy Date: Subject: Page: Last Review Status/Date: Background

Review. The Genetics of Cardiac Disease Associated with Sudden Cardiac Death

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Ion channel dysfunction and diseases of the heart

Patient Resources: Cardiac Channelopathies

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

REVIEW ARTICLES Long QT syndrome and anaesthesia

Genetic Testing for Cardiac Ion Channelopathies

WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY

Local Anesthetics. Xiaoping Du Room E417 MSB Department of Pharmacology Phone (312) ;

CARDIAC POTASSIUM CHANNEL SUBTYPES: NEW ROLES IN REPOLARIZATION AND ARRHYTHMIA

Mechanisms of Arrhythmogenesis: Focus on Long QT Syndrome (LQTS)

The long QT syndrome family of cardiac ion channelopathies: A HuGE review* Stephen M. Modell, MD, MS 1, and Michael H.

The Genetics and Prevention of Sudden Cardiac Death

Atrial fibrillation in Cardiac Channelopathies

Bear: Neuroscience: Exploring the Brain 3e

Cardiovascular diseases

La corrente tardiva del Na come nuovo target di terapia antiischemica: ruolo della ranolazina

UvA-DARE (Digital Academic Repository) Cardiac sodium channelopathies Amin, A.S.; Asghari-Roodsari, A.; Tan, H.L. Published in: Plügers Archiv

ICD in a young patient with syncope

Pharmacogenomics of Drug-Induced Conditions

Silvia G Priori MD PhD

Role of potassium currents in cardiac arrhythmias

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

In Vitro Assessment to Replace the Clinical TQT Study: The Comprehensive In Vitro ProArrhythmia Assay (CiPA) Initiative

Cardiology Genetics Report Long QT Syndrome (LQTS) Panel

Voltage Gated Ion Channels

Modeling of Anatomy, Electrophysiology and Tension Development in the Human Heart

Jaigurumajaigurumajaiguruma. Autonomic Modulation of Ventricular Repolarization in Long QT syndrome. Dr. Rajkumar Mantravadi MBBS 1994 MRCP (UK) 2002

Antiarrhythmic Drugs

The Self-Assessment Approach

Pharmacology of cardiac potassium channels

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification

Cellular Neurobiology BIPN140. 1st Midterm Exam October 18 th, Tuesday Material covered: Lectures 1-6 & Reading

FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers)

Introduction. Circulation

TABLE 1. Mutations in the Cardiac Ryanodine Receptor Gene (RyR2) Associated With CPVT and ARVD2* Amino acid Nucleotide Disease Families Familial? Doma

Etude de Maladies du Rythme Cardiaque à l'aide de Cellules Souches Pluripotentes Induites

Chapter 12: Cardiovascular Physiology System Overview

Defining new insight into fatal human arrhythmia: a mathematical analysis

About OMICS Group Conferences

Long Q. Long QT Syndrome. A Guide for

Potassium Channelopathies: Consequences and Impact on Treatment December 4, 2010

The Genetic Basis for Cardiac Dysrhythmias and the Long QT Syndrome

Sudden cardiac death (SCD) accounts for 20% of mortality. Sudden Cardiac Death Compendium. Genetics of Sudden Cardiac Death

Long QT syndrome a genetic cardiac channelopathy

1 Ions, Channels, and Currents

Hereditary Conditions Predisposing to Sudden Death

Παναγιώτης Ιωαννίδης. Διευθυντής Τμήματος Αρρυθμιών & Επεμβατικής Ηλεκτροφυσιολογίας Βιοκλινικής Αθηνών

Transport through biological membranes. Christine Carrington Biochemistry Unit Apr 2010

Chapter 3 subtitles Action potentials

Case Demonstrations in Congenital and Acquired Long QT Syndrome

1. (1 pt) At the equilibrium potential of an ion, what two things are equal? Electrical potential (voltage) and chemical potential (concentration)

Channelopathies. Review article Korean J Pediatr 2014;57(1):1-18. Introduction

Transcription:

Ionchannels and channelopaties in the heart Viktória Szőts

Action of membrane transport protein ATP-powered pump Ion chanels Transporters 10 1-10 3 ions/s 10 7-10 8 ions/s 10 2-10 4 ions/s

Cardiac K + channels control the resting membrane potentials and the amplitude, duration, refractoriness and automaticity of action potentials. K + channels share a similar structure, composed by four pore-forming α-subunits assembled as tetramers or dimers forming K + selective pores and modulated by accessory subunits. The main K + channel pore forming protein is not translated from a single gene as Na + and Ca + channels, but is made up of four separate subunits, which assembly with ß-subunits to form the functional channel More than 80 different K + channels are expressed in the heart, display considerable diversity of native K + channels. Ca-independent transient outward potassium current (I to1 ) underlies by KCNA genes encoded Kv3.x and Kv4.x proteins. Delayed rectifier currents: the rapid (I Kr ) and slow (I Ks ) are encoded by different voltage-gated K+ channel genes. I Kr is produced by theαsubunit ERG (KCNH2), in co-assemblance with the ß-subunit MiRP1 (KCNE2). I Ks is produced by theα-subunit KvLQT1 (KCNQ) assembly with the accessories subunits of mink and MIPRs (KCNE1, KCNE2, KCNE3) Inward rectifier current (I K1 ) carried by Kir 2.1, Kir 2.2 and Kir 2.3 (KCNJ2, KCNJ12 and KCNJ4) channel proteins.

Molecular composition of the cardiac K-ionchannels Selectivity filter Nerbonne et al. Circ Res. 2001;89:944-956

Membrane topology of the Kv and Kir2.x K-ionchannels Voltage gated K + channel Inward rectifier K + channel Kv channel CO 2 CO 2 CO 2 H5 H5

Kv complex MiRP N N α C C KChAP β PSD

Gating movi Ionchannels are open and close changing the permeability

Assembly of different ionchannel subunits Extracellular Intracellular Abott et al Neuropharm. 2004

Molecular assembly of ion channels Cavα Kvα Kir

Activation and Inactivation of The Sodium Channel Sodium channels are characterized by voltage-dependent activation, rapid inactivation, and selective ion conductance. Depolarization of the cell membrane opens the ion pore allowing sodium to passively enter the cell down its concentration gradient. The increase in sodium conductance further depolarizes the membrane to near the sodium equilibrium potential. Inactivation of the sodium channel occurs within milliseconds, initiating a brief refractory period during which the membrane is not excitable. The mechanism of inactivation has been modeled as a "hinged lid" or "ball and chain", where the intracellular loop connecting domains III and IV of the a subunit closes the pore and prevents passage of sodium ions.

Voltage-Gated Calcium Channels Voltage-gated calcium channels are heteromultimers composed of an α1 subunit and three auxiliary subunits, 2-δ, β and γ. The α1 subunit forms the ion pore and possesses gating functions and, in some cases, drug binding sites. Ten α1 subunits have been identified, which, in turn, are associated with the activities of the six classes of calcium channels. L-type channels have α1c (cardiac), α1d (neuronal/endocrine), α1s (skeletal muscle), and α1f (retinal) subunits; The α1 subunits each have four homologous domains (I-IV) that are composed of six transmembrane helices. The fourth transmembrane helix of each domain contains the voltage-sensing function. The four α1domains cluster in the membrane to form the ion pore. The β-subunit is localized intracellularly and is involved in the membrane trafficking of α1subunits. The γ-subunit is a glycoprotein having four transmembrane segments. The α2 subunit is a highly glycosylated extracellular protein that is attached to the membrane-spanning d-subunit by means of disulfide bonds. The α2-domain provides structural support required for channel stimulation, while the δ domain modulates the voltage-dependent activation and steady-state inactivation of the channel.

Ionic currents and ion transporters responsible for cardiac action potential Abriel H. et al., Swiss Med Wkly 2004, 685-694. www.sm w. ch

The expression and properties of these K+ channels are altered in cardiac diseases (ie. cardiac arrhythmia, Long QT syndrome, hypertrophyc cardiomyopathy, Andersen syndrome, heart failure). These K+ channels still require further investigation because they are involved in the basic normal heart rhythm, and may be altered in cardiac diseases.

Proposed cellular mechanism for the development of Torsade de pointes in the long QT syndrome

Prolonged QT interval on ECG (reflects prolonged APD) APD governed by a delicate balance between inward (Na + or Ca + ) and outward (K + ) ionic current Affecting the Na + or Ca + channel prolong APD via gain-offfunction mechanism, while mutation in genes encoding K + channel by loss-off-function mechanism

Risk factors for developing Torsade de pointes Genetic variants (polymorphysm or mutations) Abriel H. et al., Swiss Med Wkly 2004, 685-694.

Ionic current, proteins and genes associated with inherited arrhythmias Napolitano et al. Pharm. & ther. 2006,110:1-13

Congenital and aquired forms of long QT syndromes Abriel H. et al., Swiss Med Wkly 2004, 685-694. www.sm w. ch

K+, Na+ channel LQT-associated genes and proteins Current Genes Disease I To1 I Ks I Kr I Na I k1 I kur I kach I katp I CaL Kv4.3 KvLQT1(KCNQ1) Mink (KCNE1) HERG (KCNH2) MiRP1 (KCNE2) SCN5A Kir2.1 (KCNJ2) Kv1.7(KCNA7),Kv1.5 Kir3.4 Kir6.2 Cav1.2 (CACNA1c) LQT LQT1, JLN1 LQT5, JLN2 LQT2 LQT6, FAF LQT3 Brugada Syndrome, Cardiac conduction defect, Sick sinus syndrome LQT7 Andersen-Tawil Syndrome Progressziv familial heart Block1 AF LQT8 Timothy Syndrome

Gene mutations in LQT1 and LQT2 HERG KCNH2 KvLQT1 KCNQ1 LQT2 LQT1

Molecular structure and the membrane topology of the HERG channel Mutations in HERG channel

Atrial fibrillation (AF): Rapid shortening of the AERP Functional changes of ion channel Reduction of I CaL and gene expression of L-type Ca channel Increase in K+-ion channel activity of I kach, I k1 Reduction in I to and I sus Reduced gene expression in Kv1.5, Kv4.3, Kir3.1, Kir3.4, Kir6.2

Pivotal role of Ser phosphorilation as a regulatory mechanism in Cav1.2 mode1/mode2 gating. Timothy s syndrome

Current Genes Disease I Kr I K1 I Ks HERG (KCNH2) Kir2.x (KCNJ2) KvLQT1(KCNQ1) ShortQT I Ca CASQ2 CPVT catecholamine-induced (Calsequestrin2) polymorphic CPVT ventricular tachycardia I Ca RyR2 CPVT I kach β 1 -adrenoceptor (β 1 -AR) β 2 -adrenoceptor (β 2 -AR) Kv3.1, Kv3.4 Risk factor, modify disease or influence progression of disease Risk factor, modify disease or influence progression of disease AF

Complexity of protein-protein interaction in cardiomyocytes

Missense mutation in calsequestrin2 (CASQ2) wild type Syncope Seizures or Sudden death In response to Physical activity or Emotional stress mutant Associated with autosomal recessive catecholamineinduced polymorphic ventricular tachycardia (CPVT)

Kir2.1 ionchannel has an autosomal dominant mutation in Andersen-Tawil Syndrome Cardiac arrhytmias Periodic paralysis Dysmorphic bone structure(scoliosis, low-set ears, small chin, broad forehead

Facial and sceletal features in Andersen- Tawil syndrome

Kir2.1 ion channel mutation GIRK mutation

ANP role

Gene-specific mutation study Genexpression study Microarray, qrt-pcr Proteomica

Kir2.x analysis by RT-PCR kir2.x mrna in dog & human 0.01400000 0.01200000 0.01000000 0.00800000 0.00600000 0.00400000 0.00200000 0.00000000-0.00200000 Kir2.1 Kir2.2 Kir2.3 Kir2.4 HUMAN DOG

Expression of Kv1.5 protein in human and dog kda 75 66 RV LV RA LA RV LV DOG HUMAN 6 RA LA Relative amount of Kv1.5 5 4 3 2 1 0 HUMAN DOG n=12 n= 6 LV LA

Co-localization of Kvβ β2 auxillary subunit with Kv1.5 in dog left ventricular myocytes Kv1.5-FITC Kvβ β2-texas red 100 µ Kv1.5-FITC Kvβ β2-texas red